stoxline Quote Chart Rank Option Currency Glossary
  
ImageneBio Inc (IMA)
3.92  0.11 (2.89%)    11-19 15:13
Open: 3.84
High: 4
Volume: 26,075
  
Pre. Close: 3.81
Low: 3.84
Market Cap: 49(M)
Technical analysis
2026-11-19 2:45:12 PM
Short term     
Mid term     
Targets 6-month :  5.19 1-year :  6.07
Resists First :  4.44 Second :  5.19
Pivot price 3.86
Supports First :  3.55 Second :  3
MAs MA(5) :  3.69 MA(20) :  3.92
MA(100) :  4.94 MA(250) :  5.66
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  69.9 D(3) :  46.1
RSI RSI(14): 52.7
52-week High :  7.59 Low :  3
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ IMA ] has closed below upper band by 28.6%. Bollinger Bands are 66.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.99 - 4.01 4.01 - 4.02
Low: 3.73 - 3.75 3.75 - 3.77
Close: 3.77 - 3.81 3.81 - 3.84
Company Description

ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

Headline News

Thu, 12 Nov 2026
Imagenebio, Inc (IMA) Stock Price, News, Earnings & Company Profile - RTTNews

Thu, 12 Nov 2026
Here's Why We're Watching ImageneBio's (NASDAQ:IMA) Cash Burn Situation - Simply Wall St

Tue, 10 Nov 2026
ImageneBio, Inc. (IMA) Misses Q3 EPS by 11c - StreetInsider

Mon, 09 Nov 2026
ImageneBio Reports $15.6 Million Third-Quarter Net Loss - Moomoo

Mon, 09 Nov 2026
ImageneBio Reports Q3 2026 Results, $15.6 Million Net Loss - TradingView

Wed, 28 Oct 2026
ImageneBio (IMA) Jumps +3.58% — Is Institutional Money Flowing In? 2026-10-28 - Breakout Confirmation - https://www.siam.in/

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 11 (M)
Shares Float 6 (M)
Held by Insiders 16.1 (%)
Held by Institutions 54.4 (%)
Shares Short 61 (K)
Shares Short P.Month 35 (K)
Stock Financials
EPS -4.1
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 12.6
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -43.1 %
Return on Equity (ttm) -82.7 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -5.14
Qtrly Earnings Growth 0 %
Operating Cash Flow -53 (M)
Levered Free Cash Flow -23 (M)
Stock Valuations
PE Ratio -1.01
PEG Ratio 0
Price to Book value 0.32
Price to Sales 0
Price to Cash Flow -0.89
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

Stoxline iOS

Alpha Bridge iOS

OptionCalc iOS

StockChart Android

Stoxline Android

Alpha Bridge Android

OptionCalc Android